⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for esophagogastric tumors

Every month we try and update this database with for esophagogastric tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative ResectionNCT04510285
Esophagogastric...
Gastric Cancer
Gastric Tumor
Esophageal Canc...
Esophageal Neop...
Esophageal Tumo...
GastroEsophagea...
Gastroesophagea...
Gastroesophagea...
Gastroesophagea...
Trastuzumab
Pembrolizumab
18 Years - Memorial Sloan Kettering Cancer Center
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative ResectionNCT04510285
Esophagogastric...
Gastric Cancer
Gastric Tumor
Esophageal Canc...
Esophageal Neop...
Esophageal Tumo...
GastroEsophagea...
Gastroesophagea...
Gastroesophagea...
Gastroesophagea...
Trastuzumab
Pembrolizumab
18 Years - Memorial Sloan Kettering Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: